Literature DB >> 14512092

Clodronate stimulates osteoblast differentiation in ST2 and MC3T3-E1 cells and rat organ cultures.

Fumiaki Itoh1, Shigemi Aoyagi, Hanako Furihata-Komatsu, Masato Aoki, Hiroshi Kusama, Masami Kojima, Hiroshi Kogo.   

Abstract

We investigated the direct effects of various bisphosphonates on osteoblasts. At 10(-5) M, clodronate increased alkaline phosphatase activity in cultured MC3T3-E1 (osteoblast-like line) and ST2 (pluripotent mesenchymal line) cells. Etidronate significantly increased alkaline phosphatase activity at 10(-5) M only in MC3T3-E1 cells. These effects were due to an increase in alkaline phosphatase-positive cell numbers, and the differentiation-enhanced cells were capable of mineralization (von Kossa stain). Other bisphosphonates (pamidronate, alendronate, and incadronate) did not increase alkaline phosphatase activity in either cell line. In cultured rat calvariae, clodronate stimulated the expression of genes for alkaline phosphatase and osteocalcin (osteoblast-differentiation markers), but decreased the expression of the gene for tartrate-resistant acid phosphatase (osteoclast marker). Clodronate, etidronate, and incadronate inhibited protein Tyr phosphatase and Ser/Thr phosphatase activities in MC3T3-E1 cells. These data suggest that clodronate acts directly on mesenchymal cells to enhance osteoblast differentiation, and this effect may be partly expressed through inhibition of protein Tyr phosphatase and/or Ser/Thr phosphatase activity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14512092     DOI: 10.1016/j.ejphar.2003.08.011

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  12 in total

Review 1.  Novel actions of bisphosphonates in bone: preservation of osteoblast and osteocyte viability.

Authors:  Teresita Bellido; Lilian I Plotkin
Journal:  Bone       Date:  2010-08-18       Impact factor: 4.398

Review 2.  Bisphosphonates: effects on osteoblast.

Authors:  Nicola Maruotti; Addolorata Corrado; Anna Neve; Francesco Paolo Cantatore
Journal:  Eur J Clin Pharmacol       Date:  2012-02-09       Impact factor: 2.953

3.  Histochemical evidence of zoledronate inhibiting c-src expression and interfering with CD44/OPN-mediated osteoclast adhesion in the tibiae of mice.

Authors:  Hongrui Liu; Jian Cui; Jing Sun; Juan Du; Wei Feng; Bao Sun; Juan Li; Xiuchun Han; Bo Liu; Kimimitsu Oda; Norio Amizuka; Minqi Li
Journal:  J Mol Histol       Date:  2015-05-13       Impact factor: 2.611

4.  The effect of the alendronate on OPG/RANKL system in differentiated primary human osteoblasts.

Authors:  Anna Enjuanes; Silvia Ruiz-Gaspà; Pilar Peris; Dolores Ozalla; Luisa Alvarez; Andrés Combalia; M Jesús Martínez de Osaba; Ana Monegal; Albert Pares; Nuria Guañabens
Journal:  Endocrine       Date:  2010-01-07       Impact factor: 3.633

5.  The effect of the alendronate on OPG/RANKL system in differentiated primary human osteoblasts.

Authors:  Anna Enjuanes; Silvia Ruiz-Gaspà; Pilar Peris; Dolores Ozalla; Luisa Álvarez; Andrés Combalia; M Jesús Martínez de Osaba; Ana Monegal; Albert Pares; Nuria Guañabens
Journal:  Endocrine       Date:  2009-11-24       Impact factor: 3.633

6.  Bisphosphonate-induced osteonecrosis of the external ear canal: a retrospective study.

Authors:  K Froelich; A Radeloff; C Köhler; R Mlynski; J Müller; R Hagen; N H Kleinsasser
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-02-16       Impact factor: 2.503

7.  Weekly clodronate treatment prevents bone loss and vertebral fractures in women with subclinical Cushing's syndrome.

Authors:  L Tauchmanova; E Guerra; R Pivonello; M C De Martino; M De Leo; F Caggiano; G Lombardi; A Colao
Journal:  J Endocrinol Invest       Date:  2009-05       Impact factor: 4.256

8.  Rebamipide delivered by brushite cement enhances osteoblast and macrophage proliferation.

Authors:  Michael Pujari-Palmer; Shiuli Pujari-Palmer; Håkan Engqvist; Marjam Karlsson Ott
Journal:  PLoS One       Date:  2015-05-29       Impact factor: 3.240

Review 9.  Do topical applications of bisphosphonates improve bone formation in oral implantology? A systematic review.

Authors:  N Lozano-Carrascal; O Salomó-Coll; F Hernández-Alfaro; S-A Gehrke; J Gargallo-Albiol; J-L Calvo-Guirado
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2017-07-01

Review 10.  Pharmacological management of osteogenesis.

Authors:  Valeria Nardone; Federica D'Asta; Maria Luisa Brandi
Journal:  Clinics (Sao Paulo)       Date:  2014-06       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.